Chu G
Department of Medicine, Stanford University School of Medicine, California 94305.
J Biol Chem. 1994 Jan 14;269(2):787-90.
The anticancer drug cisplatin provokes a complex response in the cell. A lethal dose of the drug kills cells primarily by forming DNA adducts, causing G2 arrest in the cell cycle, and then triggering apoptosis. A sublethal dose induces drug resistance by several mechanisms, including changes in drug uptake and efflux, glutathione and metallothionein levels, and DNA repair. Cisplatin-DNA adducts bind several cellular proteins, including some that enhance survival of the cell by mediating DNA repair and others that hasten its death by conferring sensitivity to the drug.
抗癌药物顺铂在细胞中引发复杂的反应。致死剂量的该药物主要通过形成DNA加合物、导致细胞周期中的G2期阻滞,然后触发细胞凋亡来杀死细胞。亚致死剂量则通过多种机制诱导耐药性,包括药物摄取和外排的变化、谷胱甘肽和金属硫蛋白水平以及DNA修复。顺铂-DNA加合物结合多种细胞蛋白,包括一些通过介导DNA修复来提高细胞存活率的蛋白,以及其他一些通过赋予细胞对药物的敏感性来加速其死亡的蛋白。